Rabekind-CP Capsule belongs to a class of drugs called gastrointestinal agents used to treat gastroesophageal reflux disease (GERD), peptic ulcers and Zollinger-Ellison syndrome. Gastroesophageal reflux disease (GERD) occurs when stomach acid frequently flows back into the food pipe (oesophagus). Peptic ulcers are sores that develop on the inner lining of the intestine and stomach. Zollinger-Ellison syndrome is characterised by the formation of tumours in the upper part of the small intestine, which leads to excess acid production.

Rabekind-CP Capsule is a combination of two drugs: Rabeprazole (proton pump inhibitor) and Cinitapride (gastroprokinetic agent). Rabeprazole works by blocking the action of proton pumps that are involved in producing stomach acid. Thereby, it reduces the amount of acid produced by the stomach and prevents excess acid from flowing back into the food pipe. On the other hand, Cinitapride increases the food pipe movement (oesophagus), small intestine and stomach, thereby enhancing bowel movement and the digestive tract gets emptied from the food in a shorter time. Together, Rabekind-CP Capsule helps in preventing acid reflux, thereby provides relief from hyperacidity and heartburn.

Take Rabekind-CP Capsule as prescribed by your doctor. You are advised to take Rabekind-CP Capsule for as long as your doctor has prescribed it for you based on your medical condition. You may experience diarrhoea, nausea, vomiting, headache, dizziness, flatulence (gas), stomach pain, or constipation in some cases. Most of these side effects of Rabekind-CP Capsule do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Rabekind-CP Capsule or any other medicines, please tell your doctor. Rabekind-CP Capsule is not recommended for children as safety and effectiveness were not established. Avoid taking Rabekind-CP Capsule if you are pregnant, especially in the first 3 months of pregnancy as it may cause harm to the fetus. Therefore, if you are pregnant or breastfeeding, please inform your doctor before taking Rabekind-CP Capsule . Inform your doctor if you have any risk factors for reduced vitamin B12 as Rabekind-CP Capsule may reduce the absorption of vitamin B12. Drive only if you are alert as Rabekind-CP Capsule may cause drowsiness. Avoid alcohol consumption as it may lead to increased stomach acid production, thereby increasing acidity and heartburn.

Rabekind-CP Capsule is a combination of two drugs, namely: Rabeprazole and Cinitapride used to treat gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Rabeprazole blocks the action of proton pumps that are involved in producing stomach acid. Thereby, it reduces the amount of acid produced by the stomach and prevents excess acid from flowing back into the food pipe. On the other hand, Cinitapride increases the food pipe movement (esophagus), small intestine, and stomach, thereby enhancing bowel movement and the digestive tract gets emptied from the food in a shorter time. Together, Rabekind-CP Capsule helps in preventing acid reflux, thereby providing relief from hyperacidity and heartburn.

If you are allergic to Rabekind-CP Capsule or any other medicines, please tell your doctor. Rabekind-CP Capsule is not recommended for children as safety and effectiveness were not established. Avoid taking Rabekind-CP Capsule if you are pregnant, especially in the first 3 months of pregnancy as it may cause harm to the fetus. Therefore, if you are pregnant or breastfeeding, please inform your doctor before taking Rabekind-CP Capsule . If you have a stomach tumor, liver problems, bleeding, low magnesium levels in the blood, osteoporosis (weak and brittle bones), or lupus (an autoimmune disorder), inform your doctor before taking Rabekind-CP Capsule . Inform your doctor if you have any risk factors for reduced vitamin B12 as Rabekind-CP Capsule may reduce the absorption of vitamin B12. If you get any skin rash, particularly in areas exposed to sun, or have pain in joints, inform your doctor. If you are taking Rabekind-CP Capsule for more than 1 year, it may increase the risk of fracture of the spine, hip, or wrist. Drive only if you are alert as Rabekind-CP Capsule may cause drowsiness. Avoid alcohol consumption as it may lead to increased stomach acid production, thereby increasing acidity and heartburn. Rabekind-CP Capsule may decrease magnesium levels in the blood, especially if taken for more than 3 months. Therefore, regular blood tests are recommended to monitor magnesium levels. If you experience bloody or watery diarrhoea with symptoms such as stomach pain, fever, or tenderness, contact your doctor immediately.

• Regular blood tests are recommended while taking Rabekind-CP Capsule to monitor magnesium levels in the blood.
• Rabekind-CP Capsule may cause some abnormal liver enzyme and blood values. These changes are temporary and may return to normal after treatment with Rabekind-CP Capsule is discontinued.